The efficacy and safety of tirzepatide, with a special focus on cardiovascular safety, were investigated in the 52-week SURPASS-4 trial testing tirzepatide versus insulin glargine in adults with T2D and a high cardiovascular risk under inadequate glycemic control at baseline on one to three oral glucose-lowering medications (metformin, sulfonylurea, SGLT-2 inhibitor) (54, 74)
Weeks 1-4: Foundation Phase Improved sleep onset and quality (sermorelin effect) Subtle increase in energy and mood (TRT effect) Reduced morning fatigue Initial sense of improved well-being Weeks 4-8: Building Phase Noticeably better recovery from workouts Stronger exercise performance More consistent daily energy Improved libido and motivation Early body composition changes Weeks 8-12: Visible Results Phase Measurable fat loss, particularly visceral fat Noticeable muscle development and definition Skin and hair quality improvements Sustained energy and vitality Improved metabolic markers on lab work Months 3-6: Optimization Phase Continued lean mass gains Further fat reduction Enhanced cardiovascular fitness Stronger bone density Sustained quality of life improvements Optimized lab markers (IGF-1, testosterone, metabolic panel) Important Lab Markers When Using Sermorelin With TRT Comprehensive monitoring is essential with combination therapy
)
It also helps your skin cells produce more energy, resulting in healthier, younger-looking skin
Compounded semaglutide, on the other hand, is a customized medication prepared by a licensed pharmacist in a specialized compounding pharmacy
Consequently, OptumRx has opted to prefer lower-cost generic stimulants (amphetamine-dextroamphetamine IR/ER, dexmethylphenidate IR/ER, dextroamphetamine IR/ER, methylphenidate IR/ER) and a couple of preferred brands (Adderall XR, Azstarys, Vyvanse)
